1/21/25 - RIGL: new BUY mechanical trading signal.1/21/25 - RIGL: new BUY signal chosen by a rules based, mechanical trading system.
RIGL - BUY
Stop Loss @ 16.25
Entry BUY @ 21.81
Target Profit @ 27.80
Analysis:
Higher timeframe: Prices have stayed above the lower channel line of the ATR (Average True Range) Keltner Channel and reversed.
Highe
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.99 USD
17.48 M USD
179.28 M USD
17.38 M
About Rigel Pharmaceuticals, Inc.
Sector
Industry
CEO
Raul R. Rodriguez
Website
Headquarters
South San Francisco
Founded
1996
FIGI
BBG000BPWTW7
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Watchlist 2023-03-07 $OPK $RIGL $WE SPY - flat this morning as we await the second testimonial day for FED chair Powell. There has been lots of opportunity in small caps the past week so shifting focus there, also to avoid the chop that we see in large cap on Fed days.
OPK - Opko health sign deal for experimental Epstein-Barr virus
RIGL - trending upwardsLooking to take an entry at 1.05 if volume and technicals look promising for Monday. A break below $1 would turn this into a bearish play for me.
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shareholders (or potential shareholders) will be happy to see that the President, Raul Rodriguez, recently boug
Rigel Pharmaceuticals doing a thing. RIGLNot quite going to Rigel, but showing more and more promise of higher highs in the not so distant future. Looking quite optimal fractally, actually.
Fibonacci goals are in green, reversal or invalidation is in red. This post is not financial advice, make your own financial advice or pay a certified
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of RIGL is 19.10 USD — it has increased by 1.15% in the past 24 hours. Watch Rigel Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rigel Pharmaceuticals, Inc. stocks are traded under the ticker RIGL.
RIGL stock has risen by 17.63% compared to the previous week, the month change is a 1.37% rise, over the last year Rigel Pharmaceuticals, Inc. has showed a 73.59% increase.
We've gathered analysts' opinions on Rigel Pharmaceuticals, Inc. future price: according to them, RIGL price has a max estimate of 57.00 USD and a min estimate of 20.00 USD. Watch RIGL chart and read a more detailed Rigel Pharmaceuticals, Inc. stock forecast: see what analysts think of Rigel Pharmaceuticals, Inc. and suggest that you do with its stocks.
RIGL reached its all-time high on Jan 3, 2001 with the price of 1,147.50 USD, and its all-time low was 6.40 USD and was reached on Jun 13, 2022. View more price dynamics on RIGL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RIGL stock is 2.70% volatile and has beta coefficient of 1.97. Track Rigel Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rigel Pharmaceuticals, Inc. there?
Today Rigel Pharmaceuticals, Inc. has the market capitalization of 344.47 M, it has increased by 1.02% over the last week.
Yes, you can track Rigel Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Rigel Pharmaceuticals, Inc. is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
RIGL earnings for the last quarter are 0.80 USD per share, whereas the estimation was 0.45 USD resulting in a 77.48% surprise. The estimated earnings for the next quarter are 0.089 USD per share. See more details about Rigel Pharmaceuticals, Inc. earnings.
Rigel Pharmaceuticals, Inc. revenue for the last quarter amounts to 57.60 M USD, despite the estimated figure of 50.10 M USD. In the next quarter, revenue is expected to reach 43.87 M USD.
RIGL net income for the last quarter is 14.34 M USD, while the quarter before that showed 12.42 M USD of net income which accounts for 15.46% change. Track more Rigel Pharmaceuticals, Inc. financial stats to get the full picture.
No, RIGL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 28, 2025, the company has 164 employees. See our rating of the largest employees — is Rigel Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rigel Pharmaceuticals, Inc. EBITDA is 26.42 M USD, and current EBITDA margin is 14.74%. See more stats in Rigel Pharmaceuticals, Inc. financial statements.
Like other stocks, RIGL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rigel Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rigel Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rigel Pharmaceuticals, Inc. stock shows the buy signal. See more of Rigel Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.